IS5809A - Concomitant administration of ACAT and MMP inhibitors for the treatment of fat degeneration - Google Patents
Concomitant administration of ACAT and MMP inhibitors for the treatment of fat degenerationInfo
- Publication number
- IS5809A IS5809A IS5809A IS5809A IS5809A IS 5809 A IS5809 A IS 5809A IS 5809 A IS5809 A IS 5809A IS 5809 A IS5809 A IS 5809A IS 5809 A IS5809 A IS 5809A
- Authority
- IS
- Iceland
- Prior art keywords
- acat
- treatment
- mmp inhibitors
- concomitant administration
- fat degeneration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9363998P | 1998-07-21 | 1998-07-21 | |
PCT/US1999/013948 WO2000004892A2 (en) | 1998-07-21 | 1999-06-18 | Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
Publications (1)
Publication Number | Publication Date |
---|---|
IS5809A true IS5809A (en) | 2001-01-12 |
Family
ID=22239992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS5809A IS5809A (en) | 1998-07-21 | 2001-01-12 | Concomitant administration of ACAT and MMP inhibitors for the treatment of fat degeneration |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP1098662A2 (en) |
JP (1) | JP2002521328A (en) |
KR (1) | KR20010083134A (en) |
CN (1) | CN1310629A (en) |
AP (1) | AP2001002035A0 (en) |
AU (1) | AU4701799A (en) |
BG (1) | BG105162A (en) |
BR (1) | BR9912296A (en) |
CA (1) | CA2335062A1 (en) |
CZ (1) | CZ2001126A3 (en) |
EA (1) | EA200100153A1 (en) |
EE (1) | EE200100046A (en) |
HR (1) | HRP20010055A2 (en) |
HU (1) | HUP0102880A3 (en) |
ID (1) | ID30030A (en) |
IL (1) | IL140982A0 (en) |
IS (1) | IS5809A (en) |
NO (1) | NO20010291D0 (en) |
OA (1) | OA11584A (en) |
PL (1) | PL346011A1 (en) |
SK (1) | SK502001A3 (en) |
TR (1) | TR200100205T2 (en) |
WO (1) | WO2000004892A2 (en) |
YU (1) | YU3501A (en) |
ZA (1) | ZA200100294B (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020050257A (en) * | 1999-11-05 | 2002-06-26 | 로즈 암스트롱, 크리스틴 에이. 트러트웨인 | Prevention of Plaque Rupture by ACAT Inhibitors |
DOP2000000107A (en) | 1999-12-01 | 2002-09-16 | Agouron Pharmaceutical Inc | COMPOUNDS, COMPOSITIONS AND METHODS TO STIMULATE THE GROWTH AND LENGTH OF NEURONS |
AU2268401A (en) * | 1999-12-17 | 2001-06-25 | Versicor Inc | Novel succinate compounds, compositions and methods of use and preparation |
EP1314423A4 (en) * | 2000-09-01 | 2004-05-19 | Sankyo Co | Medicinal compositions |
GB0100761D0 (en) | 2001-01-11 | 2001-02-21 | Biocompatibles Ltd | Drug delivery from stents |
JP4606027B2 (en) * | 2002-04-03 | 2011-01-05 | トポターゲット ユーケー リミテッド | Carbamate compounds having piperazine bonds as HDAC inhibitors |
JP4617449B2 (en) * | 2002-07-11 | 2011-01-26 | ヴィキュロン ファーマシューティカルズ インコーポレイテッド | N-hydroxyamide derivative having antibacterial activity |
WO2011092284A1 (en) * | 2010-01-29 | 2011-08-04 | Euroscreen S.A. | Novel amino acid derivatives and their use as gpr43 receptor modulators |
CN104211695B (en) * | 2013-06-04 | 2017-04-12 | 中国医学科学院医药生物技术研究所 | Use of group of carbamyl phenylsulfonyl compounds |
US20180000817A1 (en) * | 2015-01-15 | 2018-01-04 | Biocant - Associação De Transferência De Tecnologia | Treatment of hutchinson-gilford progeria syndrome and diseases related to vascular ageing |
CN106831697B (en) * | 2017-03-15 | 2019-11-05 | 深圳市康道生物有限公司 | The effective extract component of river hazel and its application in prevention and treatment atherosclerosis |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5366987A (en) * | 1991-08-22 | 1994-11-22 | Warner-Lambert Company | Isoxazolyl-substituted alkyl amide ACAT inhibitors |
US5491172A (en) * | 1993-05-14 | 1996-02-13 | Warner-Lambert Company | N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents |
CN1192140A (en) * | 1995-08-04 | 1998-09-02 | 沃尼尔·朗伯公司 | Use of sulfamic acid derivatives, acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels |
KR20000011095A (en) * | 1996-05-17 | 2000-02-25 | 로즈 암스트롱, 크리스틴 에이. 트러트웨인 | Nonphenyl sulfoneamide as inhibitor of matrix metalloproteinase |
WO1998009934A1 (en) * | 1996-09-04 | 1998-03-12 | Warner-Lambert Company | Matrix metalloproteinase inhibitors and their therapeutic uses |
-
1999
- 1999-06-18 EE EEP200100046A patent/EE200100046A/en unknown
- 1999-06-18 ID IDW20010333A patent/ID30030A/en unknown
- 1999-06-18 IL IL14098299A patent/IL140982A0/en unknown
- 1999-06-18 OA OA1200100022A patent/OA11584A/en unknown
- 1999-06-18 EP EP99930483A patent/EP1098662A2/en not_active Withdrawn
- 1999-06-18 SK SK50-2001A patent/SK502001A3/en unknown
- 1999-06-18 CZ CZ2001126A patent/CZ2001126A3/en unknown
- 1999-06-18 HU HU0102880A patent/HUP0102880A3/en unknown
- 1999-06-18 YU YU3501A patent/YU3501A/en unknown
- 1999-06-18 AP APAP/P/2001/002035A patent/AP2001002035A0/en unknown
- 1999-06-18 JP JP2000560885A patent/JP2002521328A/en active Pending
- 1999-06-18 EA EA200100153A patent/EA200100153A1/en unknown
- 1999-06-18 BR BR9912296-0A patent/BR9912296A/en not_active IP Right Cessation
- 1999-06-18 AU AU47017/99A patent/AU4701799A/en not_active Abandoned
- 1999-06-18 CN CN99808958A patent/CN1310629A/en active Pending
- 1999-06-18 WO PCT/US1999/013948 patent/WO2000004892A2/en not_active Application Discontinuation
- 1999-06-18 KR KR1020017000930A patent/KR20010083134A/en not_active Application Discontinuation
- 1999-06-18 TR TR2001/00205T patent/TR200100205T2/en unknown
- 1999-06-18 CA CA002335062A patent/CA2335062A1/en not_active Abandoned
- 1999-06-18 PL PL99346011A patent/PL346011A1/en unknown
-
2001
- 2001-01-10 ZA ZA200100294A patent/ZA200100294B/en unknown
- 2001-01-12 IS IS5809A patent/IS5809A/en unknown
- 2001-01-17 BG BG105162A patent/BG105162A/en unknown
- 2001-01-18 NO NO20010291A patent/NO20010291D0/en not_active Application Discontinuation
- 2001-01-19 HR HR20010055A patent/HRP20010055A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ID30030A (en) | 2001-11-01 |
YU3501A (en) | 2005-06-10 |
WO2000004892A3 (en) | 2000-05-18 |
HRP20010055A2 (en) | 2002-04-30 |
HUP0102880A3 (en) | 2002-11-28 |
ZA200100294B (en) | 2002-01-10 |
CZ2001126A3 (en) | 2002-01-16 |
EA200100153A1 (en) | 2001-08-27 |
CN1310629A (en) | 2001-08-29 |
NO20010291L (en) | 2001-01-18 |
AU4701799A (en) | 2000-02-14 |
WO2000004892A2 (en) | 2000-02-03 |
IL140982A0 (en) | 2002-02-10 |
BR9912296A (en) | 2001-04-17 |
KR20010083134A (en) | 2001-08-31 |
EE200100046A (en) | 2002-06-17 |
JP2002521328A (en) | 2002-07-16 |
CA2335062A1 (en) | 2000-02-03 |
PL346011A1 (en) | 2002-01-14 |
SK502001A3 (en) | 2002-06-04 |
TR200100205T2 (en) | 2001-05-21 |
OA11584A (en) | 2004-07-20 |
AP2001002035A0 (en) | 2001-03-31 |
NO20010291D0 (en) | 2001-01-18 |
HUP0102880A2 (en) | 2002-06-29 |
BG105162A (en) | 2001-12-29 |
EP1098662A2 (en) | 2001-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS5405A (en) | Prostaglandin agonists and their use in the treatment of bone disorders | |
IS2457B (en) | Compositions of drugs (e.g. chlorpromazine and pentamidine) for the treatment of neoplastic disorders | |
IS6560A (en) | Pharmaceutical composition for the treatment of acute, persistent pain and / or nervous system pain and migraine | |
IS5500A (en) | Medicinal preparations for the stimulation and treatment of gastrointestinal disorders and related diseases | |
NO994613D0 (en) | Procedures and preparations for the treatment of sleep apnea | |
NO990296D0 (en) | The HPPD gene and inhibitors | |
NO20011964L (en) | Well treatment fluids and methods for using them | |
NO993868D0 (en) | 3-piperidyl-4-oxoquinazoline derivatives and medical preparations containing them | |
IS5898A (en) | 5HT1 receptor agonists and metoclopramide for the treatment of migraine | |
DK0927555T3 (en) | Use of cyclooxygenase-2 inhibitors for the treatment and prevention of tumors, tumor-related disorders and cachexia | |
IS5233A (en) | Diagnosis of reward deficiency syndrome and its preparations | |
IS5220A (en) | Cyclo-oxygenase-2 selective carprofen for the treatment of pain and inflammation in dogs | |
NO983576D0 (en) | Well treatment fluids and methods | |
IS7003A (en) | Aromatic sulfone hydroxyamides and their use for protease inhibition | |
IS5809A (en) | Concomitant administration of ACAT and MMP inhibitors for the treatment of fat degeneration | |
NO20002181D0 (en) | Sterilization wrap, its use and method of sterilization | |
DK1041985T3 (en) | Combination of benzocycloheptapyridine compounds and antineoplastic drugs for the treatment of prophylactic disorders | |
AU2001292019A1 (en) | Protein prenyl transferase inhibitors in the treatment of neuroinflammatory disease | |
NO20010464L (en) | Methods and Preparations for the Treatment of Gastroesophageal Reflux Syndrome | |
DK1017388T3 (en) | Pharmaceuticals containing ibuprofen and domperidone for the treatment of migraine | |
NO20012738D0 (en) | Therapeutic products and their use | |
NO20023737L (en) | Methods and Preparations for the Treatment of Inflammatory Disorder | |
IS6707A (en) | Preparation for the prevention and treatment of cancer | |
NO20013816L (en) | Benzamide derivatives and drugs containing them | |
DK1032559T3 (en) | Aminoalkylphenol derivatives for the treatment of depression and memory failure |